READS: The Educational ARDS Diagnosis Study

Sponsor
University of Toronto (Other)
Overall Status
Completed
CT.gov ID
NCT02054611
Collaborator
Unity Health Toronto (Other), Sunnybrook Health Sciences Centre (Other)
600
2
2
7
300
43.1

Study Details

Study Description

Brief Summary

Without rigorous, high-quality training materials, the results of the LUNG-SAFE study examining the global incidence and outcomes of severe lung failure (acute respiratory distress syndrome [ARDS]) could be confused by either under-recognition of patients with, or misclassification of patients without, ARDS. This problem has been previously identified with the use of the prior ARDS definitions, particularly in patients with milder severity of illness. Importantly, the chest x-ray criteria in the ARDS definition has demonstrated only moderate reliability when applied by experts, although this can be improved through the use of training radiographs (as will be used in this educational module). The investigators hypothesize that the training from the educational module will allow more accurate diagnosis of ARDS by data collectors/study coordinators participating in the LUNG-SAFE study.

Condition or Disease Intervention/Treatment Phase
  • Other: Online Educational Module
  • Other: Evaluation First (Placebo)
N/A

Detailed Description

In this LUNG-SAFE sub-study, the investigators will evaluate the effect of a brief online educational module on correctly identifying patients (i.e., standardized cases) with ARDS according to the Berlin Definition.

The investigators hypothesize that the training from the educational module will allow more accurate diagnosis of ARDS according to the Berlin Definition by participating data collectors/study coordinators.

Data collectors and study coordinators from ICUs participating in LUNG-SAFE would be randomized (by simple random number generator) to one of the following online educational streams:

  1. Educational module completion followed by evaluation

  2. Evaluation followed by educational module completion

Limited demographic data will be collected from the respondents, along with their responses to the 15 multiple choice test questions. Time spent viewing the educational module will also be collected.

Study Design

Study Type:
Interventional
Actual Enrollment :
600 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Randomized Educational ARDS Diagnosis Study (READS)
Study Start Date :
Feb 1, 2014
Actual Primary Completion Date :
Aug 1, 2014
Actual Study Completion Date :
Sep 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Educational Module First

Respondents will complete the online educational module first, followed by the evaluation

Other: Online Educational Module
A descriptive video detailing the diagnosis of ARDS according to the Berlin Definition, along with online educational materials available for review.

Placebo Comparator: Evaluation First

Respondents will complete the the evaluation first, followed by the online educational module

Other: Evaluation First (Placebo)
The respondents will view the descriptive video detailing the diagnosis of ARDS according to the Berlin Definition, along with online educational materials available for review only after they have completed the evaluation.

Outcome Measures

Primary Outcome Measures

  1. ARDS Diagnosis [up to 4 weeks]

    The number of correct responses to the evaluation component (15 multiple choice questions) of the educational module (in aggregate).

Secondary Outcome Measures

  1. ARDS Diagnosis [up to 4 weeks]

    Number of correct responses to the evaluation component of the educational modules, separated by question type (vignettes vs. chest x-rays)

  2. Time [up to 4 weeks]

    Amount of time spent completing the educational module

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Study coordinators/data collectors for the LUNG-SAFE study
Exclusion Criteria:
  • No informed consent to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sunnybrook Health Sciences Centre Toronto Ontario Canada
2 University Health Network Toronto Ontario Canada

Sponsors and Collaborators

  • University of Toronto
  • Unity Health Toronto
  • Sunnybrook Health Sciences Centre

Investigators

  • Principal Investigator: Eddy Fan, MD, PhD, University Health Network and Mount Sinai Hospital
  • Principal Investigator: Gordon Rubenfeld, MD, MSc, Sunnybrook Health Sciences Centre

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eddy Fan, Assistant Professor, University of Toronto
ClinicalTrials.gov Identifier:
NCT02054611
Other Study ID Numbers:
  • READS1
First Posted:
Feb 4, 2014
Last Update Posted:
Sep 4, 2014
Last Verified:
Sep 1, 2014
Keywords provided by Eddy Fan, Assistant Professor, University of Toronto

Study Results

No Results Posted as of Sep 4, 2014